FDA.reportPublic FDA data

NDC 67184-1006-02 - Ceftriaxone Sodium

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
67184-1006
Requested NDC
67184-1006-02
Package NDCs from labels
67184-1006-2, 67184-1006-1, 67184-1006-02
Manufacturer
Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd.(High Tech Zone Site) | Qilu Antibiotics Pharmaceutical Co., Ltd.
Effective date
2026-02-04
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Ceftriaxone for Injection, USPQilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd.(High Tech Zone Site) | Qilu Antibiotics Pharmaceutical Co., Ltd.2026-02-04HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67184-1006-1Ceftriaxone Sodium1 in 1 VIAL, SINGLE-USEINJECTION, POWDER, FOR SOLUTION14
67184-1006-1Ceftriaxone Sodium10 in 1 CARTONINJECTION, POWDER, FOR SOLUTION104
67184-1006-2Ceftriaxone Sodium1 in 1 VIAL, SINGLE-USEINJECTION, POWDER, FOR SOLUTION14
67184-1006-2Ceftriaxone Sodium1 in 1 CARTONINJECTION, POWDER, FOR SOLUTION14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
67184-1006CEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION [QILU PHARMACEUTICAL CO., LTD.]2Current NDC, Legacy NDC, 4 package rows20181121_4cdf0743-c62b-4969-b9c9-4c6400644f6c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 35 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ceftriaxone SodiumCEFTRIAXONE SODIUMSportpharm LLCddbc3bf6-5bab-4851-ae5a-ef263cd8f2552026-07-23Warnings, Adverse reactionsExact identifier
rxcui: 1665005
rxcui: 309092
rxcui: 1665021
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONEWG Critical Care, LLC86ec0a92-a552-4a6d-9125-a54f95e433922026-06-18Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMSportpharm LLC85ce4f8b-77e0-48bf-9f57-93f1478befa22026-04-24Warnings, Adverse reactionsExact identifier
application number: ANDA203702
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMSportpharm LLC9a937e47-8c36-4656-83e1-b3c18ed9bac32026-04-24Warnings, Adverse reactionsExact identifier
application number: ANDA203702
rxcui: 1665005
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMREMEDYREPACK INC.9c801096-ca61-4b29-a1e1-5f7e7813b1912026-02-06Warnings, Adverse reactionsExact identifier
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMQilu Pharmaceutical Co., Ltd.4cdf0743-c62b-4969-b9c9-4c6400644f6c2026-02-04Warnings, Adverse reactionsExact identifier
application number: ANDA203702
ndc (package): 67184-1008-1
ndc (package): 67184-1007-1
ndc (package): 67184-1006-2
ndc (package): 67184-1006-1
ndc (package): 67184-1005-1
ndc (package): 67184-1005-2
ndc (product): 67184-1005
ndc (product): 67184-1006
ndc (product): 67184-1008
ndc (product): 67184-1007
ndc11 (package): 67184100602
rxcui: 1665046
rxcui: 1665005
rxcui: 309092
rxcui: 1665021
spl id: 49f990ff-ec42-da5c-e063-6294a90aee7d
spl set id: 4cdf0743-c62b-4969-b9c9-4c6400644f6c
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc128bb292-d174-4769-b3e6-9f16617f31e32026-01-22Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc19141ccd-e66c-49a2-a794-0616028495a72026-01-19Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665005
rxcui: 309092
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc03283208-8616-4117-9d2b-aa8046017a4f2026-01-19Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665005
rxcui: 309092
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc365fc265-8e6c-432f-9fda-911f5f7fb4512026-01-16Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc36c07ebf-b091-483e-b2c4-f0fc0c2b41862026-01-16Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONEWG Critical Care, LLC7bed9b33-29e3-4f04-9766-43a21c7ad47a2026-01-07Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665021
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONEWG Critical Care, LLCbefd73ff-cb3b-4543-8a8e-bdb9b7fc1ff02025-04-07Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665005
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMSandoz Inc53df951b-2eee-44b1-bae2-df7ed85bc0ed2025-02-28Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMSandoz Incde028434-46cf-44f6-8ac6-889c7c6943b32025-02-27Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665005
rxcui: 309092
rxcui: 1665021
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONE SODIUMBaxter Healthcare Company4c5c2d3f-5038-41a1-a2fe-4dcd048dbac12024-10-07Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMA-S Medication Solutions53415af6-4072-4339-83e2-d870ae02a0e22024-08-20Warnings, Adverse reactionsExact identifier
application number: ANDA203702
rxcui: 1665005
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMA-S Medication Solutionsb642877e-0d36-4218-afe9-0a39f35b571d2024-03-27Warnings, Adverse reactionsExact identifier
rxcui: 1665005
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONECivica, Inc.96f3fc1e-84f4-4e9b-91ac-19a1692f227a2024-02-06Warnings, Adverse reactionsExact identifier
rxcui: 1665046
rxcui: 1665021
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMProficient Rx LP790279d4-2456-4091-abec-960b788854322024-02-01Warnings, Adverse reactionsExact identifier
application number: ANDA203702
rxcui: 1665005
unii: 023Z5BR09K

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.